Hany Ragy Profile picture
Cardiologist, National Heart Institute, Egypt رجاء عدم التواصل بشأن شؤون طبية خاصة علي تويتر

Aug 26, 2022, 38 tweets

Women present with more/worse HF with same risk factors #ESCCongress #Gender

Swedeheart women vs men

Female patients with HFpEF older, live longer #ESCCongress on gender differences in HF

More on Gender difference in HFpEF #ESCCongress

Sex specific factors for HF #ESCCongress

Gender different in Takotsubo #ESCCongress

Sex difference in HCM #ESCCongress

ATTR Amyloidosis gender differences

Summary , sex (gender) impacts everything in HF!
#ESCCongress

How interesting is this? #ESCCongress

Whoa!!! Gender Differences in pharmacokinetics

#ESCCongress look at one dose gender difference in Metoprolol

Digoxin women die more than placebo, is the big difference between men and women in HF meds, but most good for both #ESCCongress

#ESCCongress dosage difference between men and women, we may be hurting women by not knowing this, they are not little men!

Higher dose of Losartan good for men , not for women… wealth of data on gender differences early morning in #ESCCongress

Adverse drug effects for women underreported…#ESCCongress

More cough in ACEI in women #ESCCongress

Summary of gender drug differences #ESCCongress read it well, watch later at ESC365 @escardio

HF device gender differences, truth and misconceptions #ESCCongress

Why women benefit less from ICD’s?
Very interesting! #ESCCongress

Again, men and women are different! #ESCCongress

Powerful statement #ESCCongress

Woman benefit less with ICD? But more with CRT, but they dont get it enough! Massive data this morning at #ESCCongress on gender differences in HF

So why do women who benefit more get less CRT?#ESCCongress

Small women may not fit the QRS criteria put for bug men, time for change? #ESCCongress

May be the time has come for changing the CRT criteria to be gender specific? #ESCCongress

Short and smaller people (more women) are different, it has been studied, and should be noted #ESCCongress

Excellent conclusion in a full hall #ESCCongress

More in this excellent morning gender difference session in HF #ESCCongress

Not enough women get devices, 20% are studied in trials 😢 #ESCCongress

Same old story, women less studied, but we are all changing this! #ESCCongress

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling